Oral Rehydration Solution [ORS] Market to Exceed USD 6.71 billion by 2031, Capturing a 9.9% CAGR: TMR Report
05 oct. 2023 06h58 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The oral rehydration solution (ORS) market acquired US$ 2.55 billion in 2021. The market is...
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
10 août 2021 07h00 HE
|
AzurRx BioPharma, Inc.
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic,...
AzurRx BioPharma CEO Issues Letter to Shareholders
08 janv. 2021 09h00 HE
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., Jan. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic,...
DiaResQ Rescues Children from Diarrhea
29 juil. 2019 09h20 HE
|
PanTheryx
BOULDER, Colo., July 29, 2019 (GLOBE NEWSWIRE) -- According to The World Health Organization, pediatric diarrhea is completely preventable but still takes the lives of more children under the age of...
Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist
13 juin 2018 07h30 HE
|
Metacrine
SAN DIEGO, June 13, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine Completes $65 Million Series C Financing
06 juin 2018 07h30 HE
|
Metacrine
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine to Present Role of FXR in Treating Inflammatory Bowel Disease at Digestive Disease Week 2018
31 mai 2018 16h05 HE
|
Metacrine
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine to Present at Jefferies 2018 Global Healthcare Conference
31 mai 2018 07h30 HE
|
Metacrine
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
Metacrine Broadens Management Team with Two Key Hires
17 avr. 2018 08h00 HE
|
Metacrine
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today...
New Pathogen-Detection Technology Identifies Infectious Diseases
26 mai 2016 13h51 HE
|
ARUP Laboratories
SALT LAKE CITY, May 26, 2016 (GLOBE NEWSWIRE) -- ARUP Laboratories Medical Director Robert Schlaberg, MD, Dr Med, MPH, will be the Principal Investigator for a project to help decrease the high...